BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 22988894)

  • 1. Thrombolysis for acute ischaemic stroke with alteplase in an Asian population: results of the multicenter, multinational Safe Implementation of Thrombolysis in Stroke-Non-European Union World (SITS-NEW).
    Rha JH; Shrivastava VP; Wang Y; Lee KE; Ahmed N; Bluhmki E; Hermansson K; Wahlgren N;
    Int J Stroke; 2014 Oct; 9 Suppl A100():93-101. PubMed ID: 22988894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.
    Wahlgren N; Ahmed N; Dávalos A; Ford GA; Grond M; Hacke W; Hennerici MG; Kaste M; Kuelkens S; Larrue V; Lees KR; Roine RO; Soinne L; Toni D; Vanhooren G;
    Lancet; 2007 Jan; 369(9558):275-82. PubMed ID: 17258667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR.
    Ahmed N; Wahlgren N; Grond M; Hennerici M; Lees KR; Mikulik R; Parsons M; Roine RO; Toni D; Ringleb P;
    Lancet Neurol; 2010 Sep; 9(9):866-74. PubMed ID: 20667790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis.
    Whiteley WN; Emberson J; Lees KR; Blackwell L; Albers G; Bluhmki E; Brott T; Cohen G; Davis S; Donnan G; Grotta J; Howard G; Kaste M; Koga M; von Kummer R; Lansberg MG; Lindley RI; Lyden P; Olivot JM; Parsons M; Toni D; Toyoda K; Wahlgren N; Wardlaw J; Del Zoppo GJ; Sandercock P; Hacke W; Baigent C;
    Lancet Neurol; 2016 Aug; 15(9):925-933. PubMed ID: 27289487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolysis with alteplase for acute ischemic stroke: review of SITS-MOST and other Phase IV studies.
    Külkens S; Hacke W
    Expert Rev Neurother; 2007 Jul; 7(7):783-8. PubMed ID: 17610385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study.
    Huang X; Cheripelli BK; Lloyd SM; Kalladka D; Moreton FC; Siddiqui A; Ford I; Muir KW
    Lancet Neurol; 2015 Apr; 14(4):368-76. PubMed ID: 25726502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
    Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D;
    JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolytic therapy for acute stroke in the United Kingdom: experience from the safe implementation of thrombolysis in stroke (SITS) register.
    Lees KR; Ford GA; Muir KW; Ahmed N; Dyker AG; Atula S; Kalra L; Warburton EA; Baron JC; Jenkinson DF; Wahlgren NG; Walters MR;
    QJM; 2008 Nov; 101(11):863-9. PubMed ID: 18694900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST).
    Wahlgren N; Ahmed N; Eriksson N; Aichner F; Bluhmki E; Dávalos A; Erilä T; Ford GA; Grond M; Hacke W; Hennerici MG; Kaste M; Köhrmann M; Larrue V; Lees KR; Machnig T; Roine RO; Toni D; Vanhooren G;
    Stroke; 2008 Dec; 39(12):3316-22. PubMed ID: 18927461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset.
    Lorenzano S; Toni D;
    Int J Stroke; 2012 Apr; 7(3):250-7. PubMed ID: 22292526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study.
    Wahlgren N; Ahmed N; Dávalos A; Hacke W; Millán M; Muir K; Roine RO; Toni D; Lees KR;
    Lancet; 2008 Oct; 372(9646):1303-9. PubMed ID: 18790527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR.
    Toni D; Ahmed N; Anzini A; Lorenzano S; Brozman M; Kaste M; Mikulik R; Putaala J; Wahlgren N;
    Neurology; 2012 Mar; 78(12):880-7. PubMed ID: 22402853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extending thrombolysis to 4·5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data.
    Campbell BCV; Ma H; Ringleb PA; Parsons MW; Churilov L; Bendszus M; Levi CR; Hsu C; Kleinig TJ; Fatar M; Leys D; Molina C; Wijeratne T; Curtze S; Dewey HM; Barber PA; Butcher KS; De Silva DA; Bladin CF; Yassi N; Pfaff JAR; Sharma G; Bivard A; Desmond PM; Schwab S; Schellinger PD; Yan B; Mitchell PJ; Serena J; Toni D; Thijs V; Hacke W; Davis SM; Donnan GA;
    Lancet; 2019 Jul; 394(10193):139-147. PubMed ID: 31128925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.
    Huang Y; Sharma VK; Robinson T; Lindley RI; Chen X; Kim JS; Lavados P; Olavarría V; Arima H; Fuentes S; Nguyen HT; Lee TH; Parsons MW; Levi C; Demchuk AM; Bath PM; Broderick JP; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Pandian J; Ricci S; Stapf C; Woodward M; Wang J; Chalmers J; Anderson CS;
    Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.
    Anderson CS; Huang Y; Lindley RI; Chen X; Arima H; Chen G; Li Q; Billot L; Delcourt C; Bath PM; Broderick JP; Demchuk AM; Donnan GA; Durham AC; Lavados PM; Lee TH; Levi C; Martins SO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Silva F; Song L; Thang NH; Wardlaw JM; Wang JG; Wang X; Woodward M; Chalmers J; Robinson TG;
    Lancet; 2019 Mar; 393(10174):877-888. PubMed ID: 30739745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolysis for acute ischaemic stroke.
    Wardlaw JM; Murray V; Berge E; del Zoppo GJ
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD000213. PubMed ID: 25072528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous thrombolysis in stroke mimics: results from the SITS International Stroke Thrombolysis Register.
    Keselman B; Cooray C; Vanhooren G; Bassi P; Consoli D; Nichelli P; Peeters A; Sanak D; Zini A; Wahlgren N; Ahmed N; Mazya MV
    Eur J Neurol; 2019 Aug; 26(8):1091-1097. PubMed ID: 30793434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.
    Hacke W; Kaste M; Fieschi C; von Kummer R; Davalos A; Meier D; Larrue V; Bluhmki E; Davis S; Donnan G; Schneider D; Diez-Tejedor E; Trouillas P
    Lancet; 1998 Oct; 352(9136):1245-51. PubMed ID: 9788453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperdense middle cerebral artery sign on admission CT scan--prognostic significance for ischaemic stroke patients treated with intravenous thrombolysis in the safe implementation of thrombolysis in Stroke International Stroke Thrombolysis Register.
    Kharitonova T; Ahmed N; Thorén M; Wardlaw JM; von Kummer R; Glahn J; Wahlgren N
    Cerebrovasc Dis; 2009; 27(1):51-9. PubMed ID: 19018138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.